Mosaic ImmunoEngineering Competitors and Similar CompaniesClear all

NextCure's competitors and similar companies include TC BioPharm and Bolt Biotherapeutics.

	NextCure NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs.	TC BioPharm TC Biopharm (Holdings) is a clinical-stage cell therapy company developing immunotherapy products.	Bolt Biotherapeutics Bolt Biotherapeutics is a biotechnology company developing immunotherapeutics for multiple types of cancer.
Founding Date	Founding Date 2015	Founding Date 2013	Founding Date 2015
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare Technology biotech drug development oncology pharma platform therapy	Tags Technology biotech clinical research oncology platform therapy	Tags Technology biotech oncology platform therapy
Locations	Locations Beltsville, US HQ	Locations Holytown, GB HQ Leiden, NL Edinburgh, GB London, GB	Locations Redwood City, US HQ
Employees	Employees N/A	Employees 41	Employees 5248% decrease
Valuation ($)	Valuation ($) 39.2 m	Valuation ($) 926.7 k	Valuation ($) 25.6 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $7.7m (FY, 2025)
Net income	Net income ($55.8m) (FY, 2025)	Net income (£12.2m) (FY, 2024)	Net income ($33.4m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 160m	Total funding raised $ 33.2m	Total funding raised $ 177.5m